Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
308 , L314L324 (2015)
Mariah G
FDA-approved Crohn's treatments include biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab, risankizumab), JAK inhibitors (upadacitinib), corticosteroids for induction (budesonide, prednisone), and immunomodulators (azathioprine, methotrexate)
GLP-1 receptor agonists also have effects on inflammation and immunity, both of which can contribute to reduction in colorectal cancer risk. Researchers observed no other statistically significant associations with GLP-1 use, nor did they see any statistically significant adverse associations with any cancer type
US$ 21.61
US$ 23.38
US$ 21.65
US$ 25.78
US$ 26.36
US$ 29.90
US$ 23.73
US$ 20.62
